Elad Ziv, M.D.

University of California, San Francisco
email: eziv@itsa.ucsf.edu

Grants

Genetics of Tamoxifen Response 2008 (Cycle 14)
Translational Research Awards 14OB-0166 $803,111


Clinical and biomarker predictors of side effects from tamoxifen.
  Periodical: Breast Cancer Research and Treatment
  Author(s): Lorizio W, Wu AH, Beattie MS, Rugo H, Tchu S, Kerlikowske K, Ziv E
  Yr: 2012 Vol: 132 Nbr: 3 Pgs: 1107-18
  Associated Grant: Genetics of Tamoxifen Response
 
Estimation of tamoxifen metabolite concentrations in the blood of breast cancer patients through CYP2D6 genotype activity score.
  Periodical: Breast Cancer Research and Treatment
  Author(s): Wu AH, Lorizio W, Tchu S, Lynch K, Gerona R, Ji W, Ruan W, Ruddy KJ, et al, and Ziv E
  Yr: 2012 Vol: 133 Nbr: 2 Pgs: 677-83
  Associated Grant: Genetics of Tamoxifen Response
 
Pharmacogenetic testing affects choice of therapy among women considering tamoxifen treatment.
  Periodical: Genome Medicine
  Author(s): Lorizio W, Rugo H, Beattie MS, Tchu S, Melese T, et al, and Ziv E
  Yr: 2011 Vol: 3 Nbr: 10 Pgs: 64
  Associated Grant: Genetics of Tamoxifen Response